Do no do examples

Do no do examples for Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours
Title Year published Impact Level
Imatinib at 600 or 800 mg/day is not recommended for people with unresectable and/or metastatic gastrointestinal stromal tumours whose disease has progressed after treatment with 400 mg/day imatinib. November 2010 Unclassified